XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Summary of Reconciliation of Statutory Income Tax Rate To Effective Income Tax Rate

A reconciliation of the Company’s statutory income tax rate to its effective income tax rate in 2025 and 2024 is as follows:

 

 

2025

 

 

2024

 

 

 

Amount

 

 

Percentage

 

 

Amount

 

 

Percentage

 

Federal statutory tax rate

 

$

(46,175

)

 

 

21.00

%

 

$

(35,313

)

 

 

21.00

%

State and local income taxes, net of federal income tax effect(1)

 

 

 

 

 

%

 

 

2,132

 

 

 

(1.27

)%

Research and development credits

 

 

(3,342

)

 

 

1.52

%

 

 

(3,700

)

 

 

2.20

%

Nontaxable or nondeductible items

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

2,174

 

 

 

(0.99

)%

 

 

1,427

 

 

 

(0.85

)%

Other adjustments

 

 

13,870

 

 

 

(6.31

)%

 

 

2,130

 

 

 

(1.26

)%

Valuation allowance

 

 

33,473

 

 

 

(15.22

)%

 

 

33,441

 

 

 

(19.89

)%

Effective tax rate

 

$

 

 

 

%

 

$

117

 

 

 

(0.07

)%

(1) Massachusetts makes up the majority (greater than 50 percent) of the State taxes, net of federal benefit category.

Summary of Net Deferred Income Tax Asset

As of December 31, 2025 and 2024, the net deferred income tax asset balance related to the following (in thousands):

 

 

December 31,

 

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating losses

 

$

85,763

 

 

$

32,148

 

Capitalized research and development

 

 

57,378

 

 

 

65,606

 

Research and development credits

 

 

11,414

 

 

 

6,970

 

Equity-based compensation

 

 

9,562

 

 

 

21,035

 

Licenses

 

 

5,723

 

 

 

694

 

Accrued expenses

 

 

2,280

 

 

 

2,699

 

Basis difference on gain on 2022 sale of zipalertinib development subsidiary

 

 

1,638

 

 

 

1,700

 

Lease liability

 

 

709

 

 

 

590

 

Capitalized organizational and start-up expenses

 

 

83

 

 

 

101

 

Gross deferred tax assets

 

 

174,550

 

 

 

131,543

 

Valuation allowance

 

 

(173,785

)

 

 

(130,939

)

Net deferred tax asset

 

 

765

 

 

 

604

 

Deferred tax liability

 

 

 

 

 

 

ROU asset

 

 

695

 

 

 

457

 

Depreciation and amortization

 

 

70

 

 

 

147

 

Net deferred tax asset

 

$

 

 

$

 

Summary of Valuation Allowance The following table summarizes activity in Cullinan’s valuation allowance during 2025 and 2024 (in thousands):

 

 

2025

 

 

2024

 

Valuation allowance at beginning of year

 

$

130,939

 

 

$

87,371

 

Increases recorded to income tax provision

 

 

42,846

 

 

 

43,568

 

Increases (decreases) recorded to equity

 

 

 

 

 

 

Valuation allowance at end of year

 

$

173,785

 

 

$

130,939